Professor Gudrun Schleiermacher is a leading paediatric oncologist and researcher at Institut Curie in Paris, where she specialises in neuroblastoma and precision medicine for children with cancer.

As a physician-scientist, she combines patient care with cutting-edge research, leading international clinical trials and major European collaborations to improve treatments and outcomes for young patients.

Her work has helped identify key genetic drivers of neuroblastoma and advance more personalised treatment approaches for children worldwide.Read Prof. Schleiermacher’s Biosketch here.